Salient Capital Advisors’s MetLife MET Stock Holding History

Salient Capital Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,244	Closed	-$576K	–	237
2017 Q1	$576K	Sell	12,244 -5,462	-31%	-$260K	0.01%	170
2016 Q4	$850K	Sell	17,706 -928	-5%	-$42.6K	0.02%	133
2016 Q3	$738K	Buy	18,634 +3,132	+20%	+$118K	0.02%	130
2016 Q2	$550K	Sell	15,502 -10,961	-41%	-$427K	0.01%	162
2016 Q1	$1.04M	Buy	26,463 +4,749	+22%	+$178K	0.03%	119
2015 Q4	$933K	Sell	21,714 -6,551	-23%	-$288K	0.02%	127
2015 Q3	$1.19M	Sell	28,265 -7,627	-21%	-$356K	0.03%	122
2015 Q2	$1.79M	Buy	35,892 +10,617	+42%	+$503K	0.03%	118
2015 Q1	$1.14M	Sell	25,275 -859	-3%	-$38.6K	0.02%	132
2014 Q4	$1.26M	Buy	26,134 +2,018	+8%	+$95.9K	0.03%	139
2014 Q3	$1.16M	Buy	24,116 +4,661	+24%	+$226K	0.02%	146
2014 Q2	$963K	Buy	19,455 +1,578	+9%	+$73.8K	0.02%	144
2014 Q1	$841K	Buy	+17,877	New	+$822K	0.02%	147

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salient Capital Advisors's MET Position: Q2 2017 in Review

Salient Capital Advisors sold out of MetLife (MET) in Q2 2017, closing a stake of 12,244 shares — an estimated $576K sold.

Salient Capital Advisors first reported a position in MET in Q1 2014 and held it in 13 quarters. The position peaked at $1.79M in Q2 2015. 1,029 funds tracked by Wall St. Rank hold MET as of Q2 2017.

Salient Capital Advisors reported no remaining MetLife position as of Q2 2017 after selling out during the quarter.
Salient Capital Advisors sold 12,244 MetLife shares in Q2 2017, an estimated $576K.
Salient Capital Advisors first reported a position in MetLife in Q1 2014 and held it in 13 quarters.
Salient Capital Advisors's MetLife position peaked at $1.79M in Q2 2015.
1,029 funds tracked by Wall St. Rank held MetLife as of Q2 2017.

Based on Salient Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.